Electrical Stimulation to Improve Recovery After Peripheral Nerve Injury
Primary Purpose
Hemifacial Paralysis, Bell Palsy
Status
Terminated
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Electrical Stimulation
Sham Treatment
Sponsored by
About this trial
This is an interventional treatment trial for Hemifacial Paralysis focused on measuring unilateral facial nerve palsy, facial nerve palsy, facial palsy, facial paralysis, cross facial nerve graft, CFNG, peripheral nerve stimulation, electrical stimulation, e-stim, free muscle transfer, FMT
Eligibility Criteria
Inclusion Criteria:
Patients undergoing unilateral facial reanimation with a two-stage cross-face nerve graft and free gracilis muscle flap transfer who have;
- i) isolated unilateral facial nerve palsy and
- ii) a functioning contralateral facial nerve.
Exclusion Criteria:
- Any disorders that may compromise nerve regeneration or muscle function following muscle transfer, including diabetes, polyneuropathy, or myopathy and muscular dystrophy.
- Patients with severe cognitive impairment, which would limit their participation
Sites / Locations
- The Hospital for Sick Children
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
Electrical Stimulation
Sham Treatment
Arm Description
Electrical Stimulation The patient will receive active electrical stimulation.
No Electrical Stimulation The patient will receive sham electrical stimulation.
Outcomes
Primary Outcome Measures
Change in Pre-Operative Lip Excursion with Smile
FACEGRAM will be used to objectively analyse change in commissure excursion.
Change in Myelinated Axon Count
The number of myelinated nerve fibres that regenerate and reach the distal CFNG will be compared between groups.
Secondary Outcome Measures
Change in Facial Symmetry
FACEGRAM will be used to objectively analyse smile symmetry.
Facial Clinimetric Evaluation (FaCE) Scores
The Facial Clinimetric Evaluation (FaCE) Scale is a patient-report questionnaire assessing facial impairment and disability associated with facial paralysis. The 15-item likert scale questionnaire consists of six domains: i) facial movement, ii) facial comfort, iii) oral function, iv) eye comfort, v) lacrimal control and vi) social function.
Each domain produces its own score, with 1 meaning 'problems all the time' and 5 suggesting 'no problems at all.' The domain scores can then be summed to produce a total score assessing total quality of life with respect to facial paralysis.
Time to Reinnervation
Study participants are requested to monitor their facial movements and record any changes in a daily diary once they first notice facial movement.
Myelin Thickness
Using histomorphometry, Myelin Thickness will be used as a surrogate measure for the rate of axon regeneration.
Nerve Fibre Diameter
Using histomorphometry, Nerve Fibre Diameter will be used as a surrogate measure for the rate of axon regeneration.
Myelin Thickness/Fibre Diameter Ratio
Using histomorphometry, Myelin Thickness/Fibre Diameter Ratio will be used as a surrogate measure for the rate of axon regeneration.
Full Information
NCT ID
NCT03996525
First Posted
June 20, 2019
Last Updated
February 9, 2023
Sponsor
The Hospital for Sick Children
Collaborators
The Physicians' Services Incorporated Foundation
1. Study Identification
Unique Protocol Identification Number
NCT03996525
Brief Title
Electrical Stimulation to Improve Recovery After Peripheral Nerve Injury
Official Title
Electrical Stimulation to Improve Recovery After Peripheral Nerve Injury - A Randomized Controlled Prospective Study
Study Type
Interventional
2. Study Status
Record Verification Date
February 2023
Overall Recruitment Status
Terminated
Why Stopped
COVID-19 Pandemic
Study Start Date
September 16, 2019 (Actual)
Primary Completion Date
October 3, 2022 (Actual)
Study Completion Date
October 3, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The Hospital for Sick Children
Collaborators
The Physicians' Services Incorporated Foundation
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
After nerve injury and facial palsy, many patients have permanent muscle and sensory dysfunction. Electrical stimulation (ES) of injured nerves may speed up axon growth and improve recovery. This study will assess if ES accelerates motor axon regeneration and improves muscle recovery in patients undergoing two-staged facial reanimation for facial palsy.
This study of ES in these patients will investigate:
i) nerve regeneration over long distances;
ii) direct evidence of changes in nerve regeneration with nerve samples from the second procedure; and
iii) changes in functional outcomes in a patient population with much less variability.
Our study will provide evidence about the effect of ES in improving outcomes in patients with nerve injuries.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hemifacial Paralysis, Bell Palsy
Keywords
unilateral facial nerve palsy, facial nerve palsy, facial palsy, facial paralysis, cross facial nerve graft, CFNG, peripheral nerve stimulation, electrical stimulation, e-stim, free muscle transfer, FMT
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
7 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Electrical Stimulation
Arm Type
Experimental
Arm Description
Electrical Stimulation
The patient will receive active electrical stimulation.
Arm Title
Sham Treatment
Arm Type
Placebo Comparator
Arm Description
No Electrical Stimulation
The patient will receive sham electrical stimulation.
Intervention Type
Device
Intervention Name(s)
Electrical Stimulation
Intervention Description
Two-Stage Facial Reanimation (Standard Practice) with electrical stimulation for one hour at 20Hz (Experimental Procedure).
Cross-Facial Nerve Graft (CFNG) immediately followed by electrical nerve stimulation proximal to the coaptation site on the donor facial nerve.
Nine-to-Twelve Months later, Free Muscle Transfer (FMT) followed by electrical nerve stimulation proximal to the coaptation site in the intraoral incision.
Intervention Type
Device
Intervention Name(s)
Sham Treatment
Intervention Description
Two-Stage Facial Reanimation (Standard Practice) with sham electrical stimulation for one hour (Placebo).
Cross-Facial Nerve Graft (CFNG) followed by placement of unelectrified electrodes proximal to the coaptation site on the donor facial nerve.
Free Muscle Transfer (FMT) followed by placement of unelectrified electrodes proximal to the coaptation site in the intraoral incision.
Primary Outcome Measure Information:
Title
Change in Pre-Operative Lip Excursion with Smile
Description
FACEGRAM will be used to objectively analyse change in commissure excursion.
Time Frame
Change from Baseline (Pre-Op) over 2 Years
Title
Change in Myelinated Axon Count
Description
The number of myelinated nerve fibres that regenerate and reach the distal CFNG will be compared between groups.
Time Frame
Change from Baseline (Pre-Op) to the Final Surgery 1 Year Later
Secondary Outcome Measure Information:
Title
Change in Facial Symmetry
Description
FACEGRAM will be used to objectively analyse smile symmetry.
Time Frame
Change from Baseline (Pre-Op) over 2 Years
Title
Facial Clinimetric Evaluation (FaCE) Scores
Description
The Facial Clinimetric Evaluation (FaCE) Scale is a patient-report questionnaire assessing facial impairment and disability associated with facial paralysis. The 15-item likert scale questionnaire consists of six domains: i) facial movement, ii) facial comfort, iii) oral function, iv) eye comfort, v) lacrimal control and vi) social function.
Each domain produces its own score, with 1 meaning 'problems all the time' and 5 suggesting 'no problems at all.' The domain scores can then be summed to produce a total score assessing total quality of life with respect to facial paralysis.
Time Frame
Change from Baseline (Pre-Op) Over 2 Years
Title
Time to Reinnervation
Description
Study participants are requested to monitor their facial movements and record any changes in a daily diary once they first notice facial movement.
Time Frame
Up to 1 year after the Second Operation (FMT)
Title
Myelin Thickness
Description
Using histomorphometry, Myelin Thickness will be used as a surrogate measure for the rate of axon regeneration.
Time Frame
Change from Baseline (Pre-Op) to the Final Surgery 1 Year Later
Title
Nerve Fibre Diameter
Description
Using histomorphometry, Nerve Fibre Diameter will be used as a surrogate measure for the rate of axon regeneration.
Time Frame
Change from Baseline (Pre-Op) to the Final Surgery 1 Year Later
Title
Myelin Thickness/Fibre Diameter Ratio
Description
Using histomorphometry, Myelin Thickness/Fibre Diameter Ratio will be used as a surrogate measure for the rate of axon regeneration.
Time Frame
Change from Baseline (Pre-Op) to the Final Surgery 1 Year Later
10. Eligibility
Sex
All
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients undergoing unilateral facial reanimation with a two-stage cross-face nerve graft and free gracilis muscle flap transfer who have;
i) isolated unilateral facial nerve palsy and
ii) a functioning contralateral facial nerve.
Exclusion Criteria:
Any disorders that may compromise nerve regeneration or muscle function following muscle transfer, including diabetes, polyneuropathy, or myopathy and muscular dystrophy.
Patients with severe cognitive impairment, which would limit their participation
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kristen Davidge, MD
Organizational Affiliation
The Hospital for Sick Children
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Ronald Zuker, MD
Organizational Affiliation
The Hospital for Sick Children
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Hospital for Sick Children
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5G 1X8
Country
Canada
12. IPD Sharing Statement
Learn more about this trial
Electrical Stimulation to Improve Recovery After Peripheral Nerve Injury
We'll reach out to this number within 24 hrs